Market cap
₹30 Cr
Revenue (TTM)
₹24 Cr
P/E Ratio
--
P/B Ratio
-11.3
Div. Yield
0 %
| Soni Medicare | Lotus Eye Hosp | Aspira Pathlab | NG | Samsrita Labs | |
|---|---|---|---|---|---|
Market cap (₹ Cr) |
30 | 231 | 94 | 38 | 25 |
Revenue (₹ Cr) |
24 | 57 | 26 | 17 | 0 |
Net Profit (₹ Cr) |
-3.62 | 0.15 | -0.45 | 1.93 | -8.72 |
Net Margin (%) |
-15.36 | 0.26 | -1.72 | 10.69 | -17,442.00 |
RoE (%) |
-- | 0.26 | -3.41 | 5.30 | -60.02 |
Price to Earnings |
-- | 1,536.85 | -- | 19.86 | -- |
Price-To-Book |
-11.34 | 3.79 | 7.72 | 1.13 | 2.20 |
Income Statement (₹ Cr)
| Soni Medicare | Lotus Eye Hosp | Aspira Pathlab | NG | Samsrita Labs | |
|---|---|---|---|---|---|
|
Operating Revenue
|
23.53 | 57.25 | 25.90 | 16.90 | 0.02 |
|
Total Income
|
23.53 | 58.45 | 26.43 | 18.03 | 0.05 |
|
Total Expenditure
|
25.19 | 52.40 | 24.92 | 15.02 | 8.77 |
|
EBITDA
|
-1.66 | 4.85 | 0.99 | 1.88 | -8.75 |
|
Depreciation
|
0.52 | 4.57 | 1.58 | 0.57 | 0.00 |
|
EBIT
|
-2.18 | 0.28 | -0.59 | 1.31 | -8.75 |
|
Interest
|
1.36 | 1.25 | 0.39 | 0.06 | 0.00 |
|
Other Income
|
0.00 | 1.20 | 0.53 | 1.13 | 0.03 |
|
Exceptional Items
|
0.00 | -0.01 | 0.00 | 0.00 | 0.00 |
|
Profit before Tax
|
-3.54 | 0.23 | -0.45 | 2.38 | -8.72 |
|
Provision for Tax
|
0.08 | 0.08 | 0.00 | 0.45 | 0.00 |
|
Profit after Tax
|
-3.62 | 0.15 | -0.45 | 1.93 | -8.72 |
Liabilities (₹ Cr)
| Soni Medicare | Lotus Eye Hosp | Aspira Pathlab | NG | Samsrita Labs | |
|---|---|---|---|---|---|
|
Shareholder's Funds
|
-1.23 | 60.14 | 12.23 | 33.56 | 11.75 |
|
Minority Interest
|
0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
|
Non-Current Liabilities
|
12.27 | 13.12 | 3.08 | 0.00 | 0.09 |
|
Current Liabilities
|
15.64 | 9.34 | 3.20 | 1.90 | 2.54 |
|
Total Liabilities
|
22.17 | 69.57 | 17.46 | 41.62 | 15.57 |
Assets (₹ Cr)
| Soni Medicare | Lotus Eye Hosp | Aspira Pathlab | NG | Samsrita Labs | |
|---|---|---|---|---|---|
|
Non-Current Assets
|
6.70 | 59.70 | 8.97 | 32.40 | 11.84 |
|
Current Assets
|
17.61 | 11.37 | 4.59 | 2.94 | 2.54 |
|
Total Assets
|
22.17 | 69.57 | 17.46 | 41.62 | 15.57 |
|
Total Debt*
|
10.52 | 0.61 | 1.21 | 1.78 | 2.43 |
|
Net Current Assets
|
1.97 | 2.03 | 1.39 | 1.04 | 0.01 |
|
Contingent Liabilities
|
0.03 | 0.82 | 1.12 | 0.09 | -- |
Cashflow (₹ Cr)
| Soni Medicare | Lotus Eye Hosp | Aspira Pathlab | NG | Samsrita Labs | |
|---|---|---|---|---|---|
|
Cash From Operating Activities
|
1.47 | 2.70 | 1.83 | 1.81 | -0.23 |
|
Cash Flow from Investing Activities
|
-0.52 | -3.99 | 0.12 | -1.23 | -- |
|
Cash from Financing Activities
|
-0.24 | -1.60 | -0.99 | -0.62 | 0.22 |
|
Net Cash Inflow / Outflow
|
0.71 | -2.89 | 0.95 | -0.03 | 0.00 |
Ratios
Profitability Ratios
| Soni Medicare | Lotus Eye Hosp | Aspira Pathlab | NG | Samsrita Labs | |
|---|---|---|---|---|---|
|
ROCE (%)
|
6.58 | 3.10 | 19.27 | 23.83 | -1.79 |
|
ROE (%)
|
-12.79 | 0.26 | -3.41 | 5.30 | -60.02 |
|
ROA (%)
|
-14.80 | 0.20 | -2.52 | 5.00 | -121.26 |
|
EBIT Margin (%)
|
-9.26 | 0.50 | -2.29 | 7.75 | -48,627.78 |
|
Net Margin (%)
|
-15.36 | 0.26 | -1.72 | 10.69 | -17,442.00 |
|
Cash Profit Margin (%)
|
0.00 | 0.00 | 0.00 | 0.00 | -4.85 |
Growth Ratios
| Soni Medicare | Lotus Eye Hosp | Aspira Pathlab | NG | Samsrita Labs | |
|---|---|---|---|---|---|
|
Revenue Growth (%)
|
-25.05 | 14.08 | 14.56 | 2.15 | -- |
|
EBIT Growth (%)
|
-255.13 | -40.59 | -123.61 | 16.96 | -4.35 |
|
Net Profit Growth (%)
|
-1,029.31 | -77.38 | -117.74 | -74.09 | -3.83 |
|
EPS Growth (%)
|
-1,029.31 | -76.43 | -117.74 | -74.09 | -8.58 |
|
Book Value Growth (%)
|
-19.64 | 1.00 | 19.94 | 6.59 | -2.32 |
Valuation Ratios
| Soni Medicare | Lotus Eye Hosp | Aspira Pathlab | NG | Samsrita Labs | |
|---|---|---|---|---|---|
|
Price / Earnings
|
0.00 | 1,488.74 | -207.45 | 19.86 | -3.08 |
|
Price / Book Value
|
15.72 | 3.79 | 7.72 | 1.13 | 2.20 |
|
Dividend Yield (%)
|
0.00 | 0.00 | 0.00 | 3.06 | 0.00 |
|
EV/EBITDA
|
22.85 | 46.81 | 94.38 | 19.92 | -2.88 |
|
Market Cap (₹ Cr)
|
20.42 | 145.37 | 87.73 | 54.63 | -- |
Solvency Ratios
| Soni Medicare | Lotus Eye Hosp | Aspira Pathlab | NG | Samsrita Labs | |
|---|---|---|---|---|---|
|
Debt to Equity
|
-9.00 | 0.17 | 0.11 | 0.00 | 0.00 |
|
Short term debt to equity ratio
|
0.31 | -- | -- | 0.05 | 0.20 |
|
Current Ratio
|
1.13 | 1.22 | 1.43 | 1.55 | 1.00 |
|
Quick Ratio
|
1.07 | 0.81 | 1.22 | 1.12 | 1.00 |
|
Interest Coverage
|
-1.61 | 1.18 | -0.17 | 39.34 | -182.25 |
Operating Efficiency Ratios
| Soni Medicare | Lotus Eye Hosp | Aspira Pathlab | NG | Samsrita Labs | |
|---|---|---|---|---|---|
|
Debtors to sales (%)
|
54.17 | 2.11 | 6.69 | 2.84 | 111.11 |
|
Asset Turnover
|
0.96 | 0.75 | 1.44 | 0.44 | 0.00 |
|
Receivable days
|
96.98 | 9.50 | 38.11 | 6.31 | -- |
|
Inventory Days
|
8.69 | 25.93 | 7.95 | 15.24 | -- |
|
Payable days
|
251.51 | 80.52 | 72.32 | 0.00 | -- |
|
Cash Conversion Cycle
|
-145.84 | -45.09 | -26.26 | 21.54 | -- |